SCHEMBL6718960

SCHEMBL6718960

O=Cc1cccc(-c2ccc3cc4n(c3c2)CCNCC4)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 9/20 0.54
HTR2C P28335 9/20 0.54
TRIM24 O15164 1/20 0.37
TRIM33 Q9UPN9 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
HTR7 P34969 4/20 0.35
HTR1A P08908 3/20 0.35
CDK8 P49336 1/20 0.35
PIM2 Q9P1W9 2/20 0.33
PRKDC P78527 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6712501 0.91 HTR2A (0.54) HTR2AHTR2CTRIM24TRIM33CA12
SCHEMBL6711322 0.83 HTR2A (0.68) HTR2AHTR2CHTR7HTR1AUSP2
SCHEMBL6713998 0.81 HTR2C (0.58) HTR2AHTR2CHTR7HTR1AALDH1A1
SCHEMBL6718849 0.80 HTR2A (0.47) HTR2AHTR2CHTR7HTR1APIM2
SCHEMBL6715445 0.80 HTR2A (0.71) HTR2AHTR2CHTR7HTR1APIM2
SCHEMBL6712234 0.80 HTR2A (0.56) HTR2AHTR2CTP53CYP1A2CYP3A4
SCHEMBL6718647 0.79 HTR2A (0.52) HTR2AHTR2CHTR7HTR1AALDH1A1
SCHEMBL6713778 0.79 HTR2C (0.54) HTR2AHTR2CHTR7HTR1AALDH1A1
SCHEMBL6712296 0.79 HTR2A (0.54) HTR2AHTR2CHTR7HTR1ACDK8
SCHEMBL6712330 0.78 HTR2A (0.59) HTR2AHTR2CHTR7HTR1APIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040209870-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds ENNIS MICHAEL DALTON (US) 2004-10-21 US disclosed
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds PHARMACIA & UPJOHN COMPANY 2002-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds HTR1D, HTR1A, HTR1E HTR2A 18/4885HTR2C 7/4885TRIM24 3287/4885
US-20040209870-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds HCRTR2, NR2C2, RCOR3 HTR2A 1403/4885HTR2C 553/4885TRIM24 2486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.